Greece Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

1.1 List of Figures
1.2 List of Tables

2.1 Executive Summary
2.2 Key Highlights: Facts About the Greece Healthcare Market
2.3 Key Highlights: Healthcare Startups in Greece
2.4 Key Events: Greece Healthcare Timeline, 2016-22
2.5 Key Events: Greece Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2021-22
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Greece, 2021

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Greece
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Market Segments, Generics, Greece
3.7 Pharmaceutical Market - Market Segments, Biologics and Biosimilars, Greece
3.8 Pharmaceutical Market - Market Segment, Over-the-Counter Medicines, Greece
3.9 Pharmaceutical Market - Major Therapeutic Areas, Greece
3.10 COVID-19 Epidemiology, Greece
3.11 COVID-19 Impact and Developments in the Healthcare Market, Greece
3.12 COVID-19 Clinical Trials Landscape, Greece
3.13 Pharmaceutical Market - Major Players

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5.1 Drivers
5.2 Barriers

6.1 Deal Analysis: Pharmaceutical Market, Greece, 2020-22
6.2 Deal Analysis: Medical Device Market, Greece, 2020-22

7.1 Healthtech Landscape, Greece
7.2 Healthtech Deals Landscape, Greece
7.3 Key Healthtech Deals, Greece
7.4 Adoption of Technology in Healthcare, Greece
7.5 Major Digital Regulations, Greece
7.6 Digital Healthcare Regulations, Greece
7.7 Digital Statistics, Greece
7.8 Healthtech Landscape: Benefits and Risks, Greece

8.1 Overview of Healthcare System, Greece
8.2 Reimbursement Landscape, Greece
8.3 Overview of Insurance Providers, Greece
8.4 Healthcare Spending and Prescription Drug Price Trend, Greece
8.5 Pricing Policies, Greece
8.6 Market Access Timeline, Greece, 2013-22
8.7 Regulatory Landscape, Greece
8.8.1 Marketing Authorization for Pharmaceutical Products, Greece
8.8.2 Marketing Authorization for Biosimilars, Greece
8.8.3 Marketing Authorization for Medical Devices, Greece
8.8.4 Pharmaceutical and Medical Device Establishment Regulations, Greece
8.8.5 Intellectual Property Rights, European Patent, Greece
8.8.6 Intellectual Property Rights, European Unitary Patent, Greece
8.8.7 Intellectual Property Rights, Patents, Greece
8.8.8 Intellectual Property Rights, Trademark, Greece
8.8.9 Clinical Trial Regulation Process, Greece
8.8.10 Pharmaceutical Clinical Trials Landscape, Greece
8.8.11 Pharmaceutical Import and Export, Greece
8.8.12 Pharmaceutical Advertising Regulations, Greece
8.8.13 Pharmaceutical Licensing Regulations, Greece
8.8.14 Labeling and Packaging Regulations, Greece

9.1 Healthcare Policy Highlights- Greece
9.2 Healthcare Facilities, Greece
9.3 Life Expectancy and Immunization Rate, Greece
9.4 Environmental Health, Greece
9.5 Healthcare Personnel, Greece
9.6 Disease Burden, Greece
9.7 Healthcare Expenditure, Greece
9.8 Healthcare Spending Components and Pharmaceutical Spending, Greece

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer

Table 1: Approved biosimilars, EU, 2020-21
Table 2: COVID-19 indicators, global and Greece, 2022
Table 3: Authorized COVID-19 vaccines, Greece, 2020-22
Table 4: Available COVID-19 IVD products, Greece, 2020-22
Table 5: Available COVID-19 IVD products, Greece, 2020-22
Table 6: Medical devices market, major segments ($M), Greece, 2021
Table 7: Overview of healthcare reforms, Greece, 2018-22
Table 8: Time taken from marketing authorization to listing as per therapeutic area, Greece, 2022
Table 9: Drug pricing mechanism, Greece, 2022
Table 10: Drug prices, Greece, 2022
Table 11: New generic drugs price, Greece, 2022
Table 12: New pharmaceutical drugs price, Greece, 2022
Table 13: Trade fairs, Greece, 2022

Figure 1: Pharmaceutical market, revenue ($B), Greece, 2015-21
Figure 2: Medical devices market, revenue ($B), Greece, 2016-21
Figure 3: Healthcare start-ups in Greece, 2022
Figure 4: Country profile, Greece, 2022
Figure 5: Pharmaceutical market, revenue ($B), Greece, 2015-21
Figure 6: Pharmaceutical market, forecast revenue ($B), Greece, 2022-25
Figure 7: Pharmaceutical exports ($B), Greece, 2013-21
Figure 8: Top export partners, Greece, 2021
Figure 9: Pharmaceutical imports ($B), Greece, 2013-21
Figure 10: Top import partners, Greece, 2021
Figure 11: Framework of the Cross-departmental task force on counterfeit medicines in Greece, 2022
Figure 12: Number of Pharmacies per 100,000 population, Greece, 2019
Figure 13: Number of wholesalers, Greece, 2011-19
Figure 14: Number of pharmacies, Greece, 2011-19
Figure 15: Penetration of pharmaceuticals (volume %), Greece, 2020
Figure 16: Generic drugs average price per unit ($), Greece, 2013-19
Figure 17: OTC medicines market, revenue ($M), Greece, 2013-21
Figure 18: OTC medicines market, major categories ($M), Greece, 2021
Figure 19: OTC medicines market, major distribution channels ($M), Greece, 2021
Figure 20: Pharmaceutical consumption (million packages), Greece, 2011-18
Figure 21: Major therapeutic areas by pharmaceutical consumption (DDD per 1,000 inhabitants per day), Greece, 2019-21
Figure 22: COVID-19 (cumulative number of cases), Greece, 2020-22
Figure 23: COVID-19 (cumulative number of deaths), Greece, 2020-22
Figure 24: COVID-19 stringency index, Greece, 2020-22
Figure 25: COVID-19 containment and health index, Greece, 2020-22
Figure 26: COVID-19 vaccine dose administration (number of administered vaccine doses), Greece, 2021-22
Figure 27: COVID-19 clinical trials sponsors by count, Greece, 2020-22
Figure 28: COVID-19 clinical trials count by phase, Greece, 2020-22
Figure 29: COVID-19 clinical trials count by trial status, Greece, 2020-22
Figure 30: Medical devices market, revenue ($B), Greece 2016-21
Figure 31: Medical devices market, revenue forecast ($B), Greece 2022-27
Figure 32: Medical devices market, major segments (%), Greece, 2021
Figure 33: Hospital supplies market, revenue ($M), Greece, 2017-27
Figure 34: Cardiovascular devices market, revenue ($M), Greece, 2017-27
Figure 35: Wound care management market, revenue ($M), Greece, 2017-27
Figure 36: Orthopedic devices market, revenue ($M), Greece, 2017-27
Figure 37: Aesthetic devices market, revenue ($M), Greece, 2017-27
Figure 38: Diagnostic market, revenue ($M), Greece, 2016-21
Figure 39: Diagnostic market, revenue ($M), Greece, 2022-27
Figure 40: Medical devices market, revenue ($B) of major companies, Greece, 2021
Figure 41: Deals value and deal count, pharmaceutical market, Greece, 2020-22
Figure 42: Top therapy areas by deal count, pharmaceutical market, Greece, 2020-22
Figure 43: Deals value and deal count, subtypes, pharmaceutical market, Greece, 2020-22
Figure 44: Deals value and deal count, medical devices market, Greece, 2020-22
Figure 45: Deals value and deal count, quarterly, medical devices market, Greece, 2020-22
Figure 46: Deals value and deal count, subtypes, medical devices market, Greece, 2020-22
Figure 47: Top equipment sectors by deal value ($M), medical devices market, Greece, 2019-22
Figure 48: Top equipment sectors by deal count, medical devices market, Greece, 2019-22
Figure 49: M&A deals by quarter (by value and by number), medical devices market, Greece, 2019-22
Figure 50: VC deals by quarter (by value and by number), medical devices market, Greece, 2019-22
Figure 51: Deals value ($M), Healthtech, Greece, 2020-22
Figure 52: Deal count (number of deals), Healthtech, Greece, 2020-22
Figure 53: GDPR compliance checklist, EU, 2022
Figure 54: Overview of healthcare system, Greece, 2022, objectives, Taiwan, 2021
Figure 55: Reimbursement process, Greece, 2022
Figure 56: VHI Coverage (% of total population), Greece, 2010-18
Figure 57: OOP expenditure (% of current expenditure on health), Greece, 2013-20
Figure 58: Pharmaceutical price index in healthcare sector (Base year 2015=100), Greece, 2011-19
Figure 59: Drug pricing process, Greece, 2022
Figure 60: Drug authorization procedures, EU, 2022
Figure 61: Centralized procedure, Greece, 2022
Figure 62: Decentralized procedure, Greece, 2019
Figure 63: Mutual recognition procedure, Greece, 2019
Figure 64: Marketing authorization for pharmaceutical products, Greece, 2022
Figure 65: Conformity assessment of class I medical devices, EU, 2022
Figure 66: Conformity assessment of class IIa medical devices, EU, 2022
Figure 67: Conformity assessment of class IIb medical devices, EU, 2022
Figure 68: Conformity assessment of class III medical devices, EU, 2022
Figure 69: European patent approval process, EU, 2022
Figure 70: Unitary patent approval process, EU, 2022
Figure 71: Patent approval process, Greece, 2022
Figure 72: Pharmaceutical clinical trials count by trial status, Greece, 2020-22
Figure 73: Pharmaceutical clinical trials count by phase, Greece, 2020-22
Figure 74: Pharmaceutical clinical trials count by therapy areas, Greece, 2020-22
Figure 75: Top five pharmaceutical clinical trials sponsors by count, Greece, 2020-22
Figure 76: Medical devices clinical trials count by trial status, Greece, 2020-22
Figure 77: Medical devices clinical trials count by indication, Greece, 2020-22
Figure 78: Medical devices clinical trials count by therapeutic areas, Greece, 2020-22
Figure 79: Top five medical devices clinical trials sponsors by count, Greece, 2020-22
Figure 80: Number of hospitals, Greece, 2013-21
Figure 81: Number of diagnostic equipment units (per million population), Greece, 2015-21
Figure 82: Number of hospital beds (per 1,000 Population), Greece, 2013-21
Figure 83: Number of acute care beds (per 1,000 Population), Greece, 2015-21
Figure 84: Number of psychiatric care beds (per 1,000 Population), Greece, 2015-21
Figure 85: Life expectancy at birth (years), Greece, 2013-21
Figure 86: Immunization coverage (%), Greece, 2020
Figure 87: PM2.5 (µg per m3), Greece, 2013-21
Figure 88: CO2 emissions (Mt CO2), Greece, 2013-21
Figure 89: Physicians (per 1,000 population), Greece, 2011-21
Figure 90: Dentists (per 1,000 population), Greece, 2011-21
Figure 91: Nurses (per 1,000 population), Greece, 2012-21
Figure 92: Major causes of mortality (per 100,000 population), Greece, 2019
Figure 93: Major causes of male mortality (per 100,000 population), Greece, 2019
Figure 94: Major causes of female mortality (per 100,000 population), Greece, 2019
Figure 95: DALY (per 100,000 population), Greece, 2019
Figure 96: Healthcare expenditure as percentage of GDP (%), Greece, 2011-20
Figure 97: Public-private share (% of total health spending), Greece, 2011-20
Figure 98: Healthcare expenditure components by function (% of total health expenditure), Greece, 2020
Figure 99: Pharmaceutical spending ($ per capita), Greece, 2010-18